EQS-News: Semperit AG Holding
/ Key word(s): Disposal
Semperit finalizes sale of the remaining medical business Vienna, July 1, 2024 – Semperit has completed the sale of the medical business and transferred the remaining production and packaging of surgical gloves to the buyer of the entire medical business, the Southeast Asian Harps Global, as agreed. Combined under the discontinued operations “Surgical Operations”, these activities were most recently carried out as contract manufacturing for Harps Global. “After we had already sold and handed over the majority of the glove business to Harps in 2023, we have now been able to place the remaining part in the hands of the new, responsible owner early and terminate the contract manufacturing. This means that Semperit has exited the glove business completely, and we are concentrating 100% on implementing our growth strategy as a leading specialist in elastomer products for industry,” says Semperit’s CEO Karl Haider. The second and final closing of the sale of the medical business took place with effect from June 30, 2024, and comprised the sale of the operation for the contract manufacturing of surgical gloves in Wimpassing, Austria, and the 100% stake in the Hungarian company Sempermed Kft., which carries out their packaging in Sopron, Hungary. The sales price (cash and debt free) amounts to EUR 7 million and is subject to the usual price adjustment mechanisms.
Contact:
www.linkedin.com/company/semperit-ag
About Semperit
01.07.2024 CET/CEST This Corporate News was distributed by EQS Group AG. www.eqs.com |
Language: | English |
Company: | Semperit AG Holding |
Am Belvedere 10 | |
1100 Wien | |
Austria | |
Phone: | +43 1 79 777-310 |
Fax: | +43 1 79 777-602 |
E-mail: | judit.helenyi@semperitgroup.com |
Internet: | www.semperitgroup.com |
ISIN: | AT0000785555 |
Listed: | Vienna Stock Exchange (Official Market) |
EQS News ID: | 1936229 |
End of News | EQS News Service |
|
1936229 01.07.2024 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.